Kennedy vaccine advisers' controversial decision to scrap longstanding hepatitis B vaccine guidance has sparked concern among medical professionals. This move could potentially expose more children to the harmful virus, as experts warn that current US infection rates are low due to decades-old vaccination policies. The advisory panel, appointed by Health Secretary Robert F. Kennedy Jr., has recommended a birth dose only for newborns whose mother tests positive or whose status is unknown. This recommendation has raised eyebrows, as it contradicts the success of universal infant vaccination since 1991, which has dramatically reduced infections and saved lives. Critics argue that the panel's decision lacks evidence of new harms and that the risk of infection is outweighed by the potential benefits of vaccination. Dr. Retsef Levi, one of the advisers, questions the rationale behind exposing children to potential risks when the risk of infection is low. Disease experts caution that the Trump administration's acceptance of this recommendation could lead to a rise in hepatitis B cases, especially without a firm federal policy in place. The panel's repudiation of a safe and successful vaccine also raises concerns about the review of all routine childhood immunizations, as President Donald Trump has instructed Kennedy to study and potentially change US vaccine policies. This decision has sparked a debate on the balance between public health and individual rights, with some committee members seemingly favoring a more relaxed approach to vaccination. The impact of this reversal will be significant, making it challenging to communicate the risks to families and potentially leading to a rise in hepatitis B cases, as the disease can have long-term complications. Pediatricians and disease experts express concern that this decision could contribute to the spread of misinformation about vaccine safety, as some committee members seem to support parents' choice to opt out of vaccination. The controversy surrounding this decision highlights the importance of evidence-based policies in public health and the need for ongoing dialogue between medical professionals and policymakers.
